Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: a retrospective analysis of January–April, 2022
Chiara Sacco, Martina Del Manso, Alberto Mateo‐Urdiales, et al.
The Lancet (2022) Vol. 400, Iss. 10346, pp. 97-103
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Evaluation of Waning of SARS-CoV-2 Vaccine–Induced Immunity
Francesco Menegale, Mattia Manica, Agnese Zardini, et al.
JAMA Network Open (2023) Vol. 6, Iss. 5, pp. e2310650-e2310650
Open Access | Times Cited: 175
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 166
Insights for COVID-19 in 2023
Francisco Javier Martín‐Sánchez, Manuel Martı́nez-Sellés, José Molero, et al.
Revista Española de Quimioterapia (2022) Vol. 36, Iss. 2, pp. 114-124
Open Access | Times Cited: 69
Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years
Atsuyuki Watanabe, Ryoma Kani, Masao Iwagami, et al.
JAMA Pediatrics (2023) Vol. 177, Iss. 4, pp. 384-384
Open Access | Times Cited: 60
Safety and effectiveness of vaccines against COVID-19 in children aged 5–11 years: a systematic review and meta-analysis
Vanessa Piechotta, Waldemar Siemens, Iris Thielemann, et al.
The Lancet Child & Adolescent Health (2023) Vol. 7, Iss. 6, pp. 379-391
Open Access | Times Cited: 51
SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era
Haifa Khemiri, Kaouther Ayouni, Henda Triki, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 63
Covid-19 Vaccine Protection among Children and Adolescents in Qatar
Hiam Chemaitelly, Sawsan AlMukdad, Houssein H. Ayoub, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 20, pp. 1865-1876
Open Access | Times Cited: 55
Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period
Pilar Tavares Veras Florentino, Flávia Jôse Oliveira Alves, Thiago Cerqueira‐Silva, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 47
Effectiveness of an inactivated SARS-CoV-2 vaccine in children and adolescents: a large-scale observational study
Alejandro Jara, Eduardo A. Undurraga, Juan Carlos Flores, et al.
The Lancet Regional Health - Americas (2023) Vol. 21, pp. 100487-100487
Open Access | Times Cited: 22
Immunogenicity, effectiveness, and safety of COVID-19 vaccines among children and adolescents aged 2–18 years: an updated systematic review and meta-analysis
Peng Gao, Liangyu Kang, Jue Liu, et al.
World Journal of Pediatrics (2023) Vol. 19, Iss. 11, pp. 1041-1054
Open Access | Times Cited: 21
Real-World Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents
Qiong Wu, Jiayi Tong, Bingyu Zhang, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 2, pp. 165-176
Open Access | Times Cited: 13
COVID-19 Vaccination and Incidence of Pediatric SARS-CoV-2 Infection and Hospitalization
Jennifer R. Head, Philip A. Collender, Tomás M. León, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e247822-e247822
Open Access | Times Cited: 12
Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England
Emma Copland, Martina Patone, Defne Saatci, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Vaccination against COVID-19 — risks and benefits in children
Alasdair Munro, Christine E. Jones, Saul N. Faust
European Journal of Pediatrics (2024) Vol. 183, Iss. 3, pp. 1107-1112
Open Access | Times Cited: 9
Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age
Farid Khan, Jennifer L. Nguyen, Tanya Singh, et al.
JAMA Network Open (2022) Vol. 5, Iss. 12, pp. e2246915-e2246915
Open Access | Times Cited: 31
Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants: test negative, case-control study
Juan Manuel Castelli, Analía Rearte, Santiago Olszevicki, et al.
BMJ (2022), pp. e073070-e073070
Open Access | Times Cited: 29
Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort study
D. Y. Lin, Yangjianchen Xu, Yu Gu, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 11, pp. 1257-1265
Open Access | Times Cited: 19
Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: a target trial emulation
Sivan Gazit, Yaki Saciuk, Galit Perez, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 7, pp. e495-e505
Open Access | Times Cited: 17
BNT162b2 Vaccine Effectiveness Against the SARS-CoV-2 Omicron Variant in Children Aged 5 to 11 Years
Eun Jung Jang, Young June Choe, Ryu Kyung Kim, et al.
JAMA Pediatrics (2023) Vol. 177, Iss. 3, pp. 319-319
Open Access | Times Cited: 15
Current state of COVID-19 in children: 4 years on
Annabel Powell, Alexander C. Dowell, Paul Moss, et al.
Journal of Infection (2024) Vol. 88, Iss. 5, pp. 106134-106134
Open Access | Times Cited: 6
The effect of COVID-19 vaccine to the Omicron variant in children and adolescents: a systematic review and meta-analysis
Wenting Lu, Shuai Zeng, Yuan Yao, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 6
Proactive vs. reactive COVID-19 screening in schools: lessons from experimental protocols in France during the Delta and Omicron waves
Elisabetta Colosi, Bruno Lina, Christelle Elias, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
COVID-19 vaccination: challenges in the pediatric population
Alice Azoicăi, Ingrith Miron, Ancuţa Ignat, et al.
Frontiers in Public Health (2025) Vol. 12
Open Access
Protection afforded by post-infection SARS-CoV-2 vaccine doses: A cohort study in Shanghai
Bo Zheng, Bronner P. Gonçalves, Pengfei Deng, et al.
eLife (2025) Vol. 13
Open Access
COVID-19 vaccine effectiveness in the paediatric population aged 5–17 years: a multicentre cohort study using electronic health registries in six European countries, 2021 to 2022
Patrícia Soares, Ausenda Machado, Nathalie Nicolay, et al.
Eurosurveillance (2025) Vol. 30, Iss. 8
Open Access
Page 1 - Next Page

Scroll to top